Natera, Inc. (NTRA)
NASDAQ: NTRA · Real-Time Price · USD
163.02
+4.58 (2.89%)
At close: Aug 15, 2025, 4:00 PM
163.85
+0.83 (0.51%)
After-hours: Aug 15, 2025, 7:52 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2013 - 2019 |
Insurance Carriers | 1.57B | Log In | Log In | Log In | Log In | Upgrade |
Insurance Carriers Growth | 47.80% | Log In | Log In | Log In | Log In | Upgrade |
Laboratory Partners | 97.21M | Log In | Log In | Log In | Log In | Upgrade |
Laboratory Partners Growth | 7.15% | Log In | Log In | Log In | Log In | Upgrade |
Patients | 27.88M | Log In | Log In | Log In | Log In | Upgrade |
Patients Growth | 12.44% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2013 - 2019 |
United States | 1.66B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | 45.13% | Log In | Log In | Log In | Log In | Upgrade |
Americas, excluding US | 6.62M | Log In | Log In | Log In | Log In | Upgrade |
Americas, excluding US Growth | 20.89% | Log In | Log In | Log In | Log In | Upgrade |
Europe, Middle East, India, Africa | 23.88M | Log In | Log In | Log In | Log In | Upgrade |
Europe, Middle East, India, Africa Growth | 9.34% | Log In | Log In | Log In | Log In | Upgrade |
Asia Pacific and Other | 8.66M | Log In | Log In | Log In | Log In | Upgrade |
Asia Pacific and Other Growth | 32.84% | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2013 - 2019 |
Tests Processed | 3.06M | Log In | Log In | Log In | Log In | Upgrade |
Tests Processed Growth | 12.21% | Log In | Log In | Log In | Log In | Upgrade |
Tests Accessioned | 3.00M | Log In | Log In | Log In | Log In | Upgrade |
Tests Accessioned Growth | 12.81% | Log In | Log In | Log In | Log In | Upgrade |
Tests Reported in Laboratory | 2.87M | Log In | Log In | Log In | Log In | Upgrade |
Tests Reported in Laboratory Growth | 12.69% | Log In | Log In | Log In | Log In | Upgrade |
Tests Reported | 2.93M | Log In | Log In | Log In | Log In | Upgrade |
Tests Reported Growth | 12.09% | Log In | Log In | Log In | Log In | Upgrade |